Industry Insight
Discovery Technology
Analytical Laboratory Technology
Delivery Systems
Ingredients, Formulation and Finishing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
   Or select

Or become a subscriber

A Flexible Biopharmaceutical Manufacturing Strategy

Companies with flexible manufacturing capabilities are in the best position to take advantage of global tax and labour opportunities, to adapt quickly to changing markets and to make the most efficient use of capacity.

By Geoffrey Hodge at Xcellerex, Inc (February 2006)

Keywords: Biopharmaceutical Manufacturing Strategy global tax and labour opportunities capacity

    View full article    |    Back to Manufacturing section

Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |